Challenge to US drug price negotiation program revived by appeals court
By Brendan Pierson (Reuters) – A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever
By Brendan Pierson (Reuters) – A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever
By Ross Kerber (Reuters) – Media company Fox can avoid a shareholder vote on a measure asking it to consider different labels for
(Reuters) -Shares of Trump Media & Technology Group fell 5% on Friday as the Truth Social parent extended this week’s steep selloff
In a recent transaction, John S. Koudounis, Vice President of the Calamos Long/Short Equity & Dynamic Income Trust (NASDAQ:CPZ), sold his entire
By Mike Stone WASHINGTON (Reuters) – The United States is preparing a $375 million military aid package for Ukraine, breaking a months-long trend
By Timothy Gardner and Laila Kearney WASHINGTON (Reuters) – The U.S. Nuclear Regulatory Commission (NRC) said on Friday it has not yet gotten
By Tom Sims and Christian Kraemer FRANKFURT (Reuters) -Germany will not sell any more shares in Commerzbank (ETR:CBKG) for now and the bank’s
By Howard Schneider WASHINGTON (Reuters) – U.S. Federal Reserve Governor Christopher Waller, one of the more ardent voices in the central bank’s battle
By Giuseppe Fonte ROME (Reuters) – Italy will probably balance its primary budget this year, excluding interest payments on government debt, the economy
WASHINGTON (Reuters) – U.S. President Joe Biden on Friday said it was critical for Congress to pass a stopgap spending bill, which